Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Medical Center, 1051 Riverside Drive, Unit 120, New York, NY, 10032, USA.
Drug Alcohol Depend. 2018 Jul 1;188:318-327. doi: 10.1016/j.drugalcdep.2018.04.018. Epub 2018 May 25.
The hypocretin/orexin system is involved in regulating arousal, and much recent work demonstrates that decreasing hypocretin receptor-1 (HCRTr1) activity using antagonists decreases appetitive behavior, including stimulant drug self-administration and reinstatement.
The present study determined the effects of hypocretin-1 and HCRTr1 antagonists on responding reinforced by intravenous (i.v.) cocaine self-administration (0.0125 - 0.05 mg/kg/infusion) in 5 female rhesus monkeys. Responding was examined using 3 schedules of reinforcement: 1) a Fixed interval 1 min, Fixed ratio 10 Chain schedule [FI 1-min (FR10:S)], 2) a Progressive Ratio (PR) schedule, and 3) a cocaine vs. candy.
Choice schedule: the HCRTr1 antagonist SB-334867 (8-24 mg/kg, i.m.) decreased cocaine taking under the Chain schedule and PR schedule in all 5 monkeys and in 4 of the 5 monkeys under the Choice schedule. d- Amphetamine (0.06 - 0.25 mg/kg, i.m.), tested as a control manipulation, decreased cocaine taking in all 5 monkeys under the Chain schedule. The peptide hypocretin-1 (0.072 mg/kg, i.v.) increased cocaine taking in the monkeys with low rates of cocaine taking under the Chain (3/4) and Choice (4/5) schedules. Reinstatement of extinguished cocaine responding following response-independent delivery of a large dose of cocaine (0.3 mg/kg) was attenuated in 3 of the 5 monkeys by the HCRTr1 antagonist SB-334867.
These data expand upon work accomplished in predominantly male rodents suggesting that the hypocretin system modulates the response to appetitive stimuli. A better understanding of this system offers promise as a novel approach in medication development for appetitive disorders.
下丘脑泌素/食欲素系统参与调节觉醒,大量近期研究表明,使用拮抗剂降低食欲素受体-1(HCRTr1)活性可减少食欲行为,包括兴奋剂药物自我给药和复吸。
本研究在 5 只雌性恒河猴中确定了下丘脑泌素-1 和 HCRTr1 拮抗剂对静脉内(i.v.)可卡因自我给药(0.0125-0.05mg/kg/输注)强化反应的影响。使用 3 种强化方案检查反应:1)固定间隔 1 分钟,固定比率 10 连锁方案[FI 1 分钟(FR10:S)],2)渐进比率(PR)方案,和 3)可卡因与糖果。
选择方案:HCRTr1 拮抗剂 SB-334867(8-24mg/kg,im)降低了所有 5 只猴子在连锁方案和 PR 方案下的可卡因摄入量,在 4 只猴子中降低了 5 只猴子在选择方案下的可卡因摄入量。d-苯丙胺(0.06-0.25mg/kg,im),作为对照操作进行测试,降低了所有 5 只猴子在连锁方案下的可卡因摄入量。肽下丘脑泌素-1(0.072mg/kg,iv)增加了在连锁方案(3/4)和选择方案(4/5)下可卡因摄入量较低的猴子的可卡因摄入量。在 5 只猴子中的 3 只中,HCRTr1 拮抗剂 SB-334867 减弱了在大剂量可卡因(0.3mg/kg)非依赖性给药后消退的可卡因反应的复吸。
这些数据扩展了在主要雄性啮齿动物中完成的工作,表明下丘脑泌素系统调节对食欲刺激的反应。对该系统的更好理解为食欲障碍的药物开发提供了新的方法。